When it came to Medicare, Obama reiterated his determination to accept only limited cost-cutting proposals. Among the ideas he appeared to reference was requiring pharmaceutical companies to charge Medicare the lower rates they currently receive from Medicaid, the federal-state health insurance program for the poor.
Obama also mentioned asking “more from our wealthiest seniors”—presumably a proposal to increase the Medicare premiums that higher income seniors pay. And he noted that his 2010 health-care law already contains measures aimed at slowing the growth of Medicare spending.
Read the full story: http://wapo.st/VTpCKA
Source: The Washington Post
Health Affairs Challenges Systemic Racism in Health Care
October 2nd 2023The October issue of Health Affairs examines the multifaceted aspects of structural racism in health care, exploring historical roots, policy implications, public biases, innovative solutions, and institutional challenges, urging action to confront and dismantle disparities.
Read More
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Insufficient Data, Disparities Plague Lung Cancer Risk Factor Documentation
September 24th 2023On this episode of Managed Care Cast, we speak with the senior author of a study published in the September 2023 issue of The American Journal of Managed Care® on the importance of adequate and effective lung cancer risk factor documentation to determine a patient's eligibility for screening.
Listen
Scientists Whose Work on mRNA Allowed Development of COVID-19 Vaccines Win Nobel Prize
October 2nd 2023Katalin Karikó, PhD, and Drew Weissman, MD, PhD, were cited "for their discoveries concerning nucleoside base modifications that enabled the development of effective mRNA vaccines against COVID-19."
Read More
2 Clarke Drive
Cranbury, NJ 08512